The Pathogen-Based Loyalty Enhancement Program represented a research initiative of the Imperial forces, financially supported by COMPNOR. The program's objective was to identify a pathogenic illness capable of constant antigenic variation, rendering its eradication impossible. The developed disease was intended for deployment on rebellious planets, followed by the arrival of Imperial forces bearing a supposed "cure"—an antiviral injection that, in reality, introduced new iterations of the disease into the population. The program aimed to create allegiance to the Empire by compelling people to accept the Imperial remedy, thus ensuring their reliance on it for continued existence. The efforts of Doctor Fesjo Negleem culminated in the creation of the FNV-23 virus, which underwent successful trials on the world of Sedesia. Nevertheless, operatives from the Rebel Alliance successfully disrupted Doctor Negleem's scheme, acquiring comprehensive documentation pertaining to the program.